Pneumococcal Vaccine Market Anticipates Outshining by USD 8.4 BN BY 2026
Posted On May 11, 2020
The Global Pneumococcal Vaccine Market value is expected to grow by an impressive 2.49% of CAGR during the forecast period of 2020 to 2026. The market was valued approximately at USD 7 BN in 2020 and can grow to USD 8.4 BN by 2026 as per the report by Value Market Research. The surge in governmental support among several economies across the globe in creating awareness about vaccination programs, rising prevalence of the contaminations within the masses, and the introduction of pneumococcal vaccines are key factors propelling the growth of the global pneumonia vaccine market. However, the production of pneumococcal vaccines needs longer time-span and higher costs, which is most likely to inhibit the growth pace.
Pneumococcal disease refers to bacterial infection caused by called Streptococcus pneumonia. This bacteria spreads from p2p direct contact via respiratory secretions, like saliva or mucus. The infections can range from a straightforward ear infection to pneumonia and blood infections. Thus, the symptoms and associated complications are dependent on the body part where the bacteria attacks or infects. The treatment used for preventing pneumococcal disease is called a pneumococcal vaccine. The vaccination is given to children who are less than 24 months and adults 65 years and older. The dose patterns of the vaccines are 2,4,6, and 12 through 15 months old for children; and a single dose will be given for the adults falling at 65 or older. The vaccine helps to provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs.
The first chapter of the report "Global Pneumococcal Vaccine Market Report By Product Type (Pneumococcal Polysaccharide Vaccines And Pneumococcal Conjugate Vaccines), Distribution Channel (Pharmacies, Community Clinics, Public Health Agencies, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026" gives the market introduction with a crisp summary of the report and goes in detailed revenue analysis bifurcated as per segments and regions in the subsequent chapters. The report analyses the trends of the past years along with deeply studying the geo-political trends, thus authenticating the findings of the research and making it more reliable.
By product type the pneumococcal vaccine market is segmented into pneumococcal polysaccharide vaccines and pneumococcal conjugate vaccines. On the basis of distribution channel the pneumococcal vaccine market is segmented into pharmacies, community clinics, public health agencies, and others.
The regions - North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa are deeply studied with respect to all the pneumococcal vaccine market segments covered in the report. The regional research assists in taking informed decision related to the regional strategic plans.
The Report Segments Global Pneumococcal Vaccine Market -
By Product Type
- Pneumococcal Polysaccharide Vaccines
- Pneumococcal Conjugate Vaccines
By Distribution Channel
- Community Clinics
- Public Health Agencies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Players Profiled In the Report:
GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and others.
Download the FREE SAMPLE of Global Pneumococcal Vaccine Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]